Will Opioids Be Replaced Anytime Soon?
Arena Pharmaceuticals has been focused recently on researching and developing a non-opiate for the treatment of gastrointestinal…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2018
California Governor Signs SB 212 Into Law
We previously wrote about the California legislation that established a statewide take-back system for sharps and medications. On…
OIG Adds to Its Work Plan
Between August and September 2018, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) added…
FDA Holds Public Meeting on Biosimilar Action Plan
On September 4, 2018, the United States Food and Drug Administration (FDA) held a public meeting to gather stakeholder input on…
CMS Announces 2019 Open Payment Reporting Thresholds
CMS updates key reporting thresholds for applicable manufacturers and group purchasing organizations (GPOs) annually for Open…
Physician in Ontario? Your Annual Income Could Be Public Information.
The Court of Appeal for Ontario recently ruled that the public has a general right know the names of top billing doctors within…
Senate Passes Opioid Legislation with Overwhelming Bipartisan Support…
On Wednesday afternoon, October 3, 2018, the United States Senate accomplished a rare feat – passing a bipartisan bill with a vote…
AmerisourceBergen Resolves Civil Fraud Charges, Agrees To Pay $625 Million
On Monday, October 1, 2018, the United States Department of Justice (DOJ) announced a $625 million agreement to resolve civil…
HHS Claims Lower Drug Prices Following “American Patients First” Blueprint
On May 11, 2018, the White House announced its American Patients First Blueprint aimed at reducing drug prices. Following the…
July 2018 Record High Month for Generic Drug Approvals
The United States Food and Drug Administration (FDA) approved – or tentatively approved – a record of 126 generic drugs in July…